India's drug tests
Article Abstract:
Multinational companies are planning to launch their clinical trials in India, as the average cost in India is low and take the advantage of its population resource and the increasing number of illness to find cures. The consultancy firm McKinsey estimates that US and Europe based pharmaceutical companies would spend US$1.5 billion per year on clinical trials in India by the year 2010.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Animal-rights militancy exported to US and Europe
Article Abstract:
Illegal tactics of extreme UK animal-rights groups are being adopted by US and European activists with law enforcers admitting that there is an increase in extremist activity on mainland Europe directly related to that in UK. Better policing and tough laws have seen UK activity shift abroad with major UK activist groups having active branches in US and other European countries.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
India in demand
Article Abstract:
Some of the drug companies of the United States have relocated their administrative tasks, including payroll and computer support overseas, especially in India. These drug companies are outsourcing work as it is much cheaper and it helps them to cut down on their cost.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Stronger territorial responses to frequency modulated coos in collared doves. Perceptual salience of acoustic differences between conspecific and allospecific vocalizations in African collared-doves
- Abstracts: Analysts seek proof of military precision. A constant problem. US particle physics fight for survival
- Abstracts: Costs discourage European patents. Showdown for Europe. Pressured staff 'lose faith' in patent quality
- Abstracts: A giant periodic flare from the soft gamma-ray repeater SGR1900+14. A new gamma-ray burst classification scheme from GRB 060614
- Abstracts: Doubling the estimate of invertebrate biomass in a rainforest canopy. FKF1 is essential for photoperiodic-specific light signalling in Arabidopsis